Ao Nong Life Science: Multiple shareholders plan to reduce their holdings.

AoNong Bio announced that as of the disclosure date, Foreign Trade Trust holds 65 million shares, accounting for 2.4972%; Xiamen Trust holds 123 million shares, accounting for 4.7254%; Beijing Yawen holds 20 million shares, accounting for 0.7684%. The three parties plan to reduce their holdings through centralized bidding by no more than 15.66 million shares, 5.5433 million shares, and 4.8203 million shares respectively from 15 trading days later to May 25, 2026, with a total proportion not exceeding 1% of the company's total share capital.